Neurosense Therapeutics Ltd (NRSN) stock is down -10.89% since Thursday, December 9, 2021, when Neurosense Therapeutics Ltd began trading. InvestorsObserver’s proprietary ranking system, gives the NRSN title a score of 22 out of a possible 100.
This ranking is primarily influenced by a long-term technical score of 0. The NRSN ranking also includes a fundamental score of 0. The NRSN short-term technical score is 67.
What’s Happening With NRSN Stock Today
Shares of Neurosense Therapeutics Ltd (NRSN) fell -3.96% while the S&P 500 was up 0.44% at 11:23 a.m. on Monday April 4. NRSN is down -$0.15 from the previous closing price of $3.75 on volume of 170,207 shares. Over the past year, the S&P 500 is down -2.18% while the NRSN is down -10.89%. NRSN has lost -$0.46 per share over the past 12 months. Click here for the full Neurosense Therapeutics Ltd stock report.
Stay in the know
Subscribe to our daily morning update newsletter and never miss market news, moves and more.